Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R-O Fourcade

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Annales D'Urologie|March 21, 2007
[Management of patients with benign prostatic hyperplasia by urologists: the DUO study]R O Fourcade, M C Picot, A F Gaudin, et al.
Urology|July 1, 1981
Endoscopic internal urethrotomy for treatment of urethral strictures: midterm surveyR O Fourcade, F Mathieu, C Chatelain, et al.
International Journal of Clinical Practice|May 16, 2008
Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical managementM Emberton, E B Cornel, P F Bassi, et al.
Japanese Journal of Clinical Oncology|April 1, 1992
Bladder reconstruction with ileum after cystoprostatectomy for bladder cancer: analysis of the micturition and continence of 44 consecutive patientsP Coloby, B Gattegno, R O Fourcade, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 5, 2013
[Perceptions of benign prostatic hyperplasia according to the perspective of patients and general practitioners - the Trophée study]F Lacoin, R-O Fourcade, M Rouprêt, et al.
European Urology|January 1, 1990
Total androgen blockade with Zoladex plus flutamide vs. Zoladex alone in advanced prostatic carcinoma: interim report of a multicenter, double-blind, placebo-controlled studyR O Fourcade, G Cariou, P Coloby, et al.
The Prostate|October 1, 1996
Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study GroupA Radlmaier, H U Eickenberg, M S Fletcher, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Annales D'Urologie|March 21, 2007
[Management of patients with benign prostatic hyperplasia by urologists: the DUO study]R O Fourcade, M C Picot, A F Gaudin, et al.
Urology|July 1, 1981
Endoscopic internal urethrotomy for treatment of urethral strictures: midterm surveyR O Fourcade, F Mathieu, C Chatelain, et al.
International Journal of Clinical Practice|May 16, 2008
Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical managementM Emberton, E B Cornel, P F Bassi, et al.
Japanese Journal of Clinical Oncology|April 1, 1992
Bladder reconstruction with ileum after cystoprostatectomy for bladder cancer: analysis of the micturition and continence of 44 consecutive patientsP Coloby, B Gattegno, R O Fourcade, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 5, 2013
[Perceptions of benign prostatic hyperplasia according to the perspective of patients and general practitioners - the Trophée study]F Lacoin, R-O Fourcade, M Rouprêt, et al.
European Urology|January 1, 1990
Total androgen blockade with Zoladex plus flutamide vs. Zoladex alone in advanced prostatic carcinoma: interim report of a multicenter, double-blind, placebo-controlled studyR O Fourcade, G Cariou, P Coloby, et al.
The Prostate|October 1, 1996
Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study GroupA Radlmaier, H U Eickenberg, M S Fletcher, et al.
Pageof 3